Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.

Maznyczka AM, McCartney PJ, Eteiba H, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, McEntegart M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Weir RA, Ford TJ, Petrie MC, Murphy A, Petrie CJ, Ramparsad N, Wetherall K, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.

Circ Cardiovasc Interv. 2020 Feb;13(2):e008855. doi: 10.1161/CIRCINTERVENTIONS.119.008855. Epub 2020 Feb 11. No abstract available.

PMID:
32069113
2.

Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database.

Kinnaird T, Johnson T, Anderson R, Gallagher S, Sirker A, Ludman P, de Belder M, Copt S, Oldroyd K, Banning A, Mamas M, Curzen N.

JACC Cardiovasc Interv. 2020 Feb 10;13(3):346-357. doi: 10.1016/j.jcin.2019.10.007.

PMID:
32029252
3.

Complex high-risk and indicated percutaneous coronary intervention for stable angina: Does operator volume influence patient outcome?

Kinnaird T, Gallagher S, Spratt JC, Ludman P, de Belder M, Copt S, Anderson R, Walsh S, Hanratty C, Curzen N, Banning A, Mamas M.

Am Heart J. 2020 Jan 7;222:15-25. doi: 10.1016/j.ahj.2019.12.019. [Epub ahead of print]

PMID:
32004796
4.

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: Rationale and design of the FORECAST trial.

Mahmoudi M, Nicholas Z, Nuttall J, Bresser M, Maishman T, Berry C, Hlatky MA, Douglas P, Rajani R, Fox K, Curzen N.

Cardiovasc Revasc Med. 2019 Dec 9. pii: S1553-8389(19)30805-X. doi: 10.1016/j.carrev.2019.12.009. [Epub ahead of print]

PMID:
31932171
5.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.

Tomaniak M, Chichareon P, Klimczak-Tomaniak D, Takahashi K, Kogame N, Modolo R, Wang R, Ono M, Hara H, Gao C, Kawashima H, Rademaker-Havinga T, Garg S, Curzen N, Haude M, Kochman J, Gori T, Montalescot G, Angiolillo DJ, Capodanno D, Storey RF, Hamm C, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Serruys PW, Anderson R.

Clin Res Cardiol. 2020 Jan 10. doi: 10.1007/s00392-019-01586-9. [Epub ahead of print]

PMID:
31925529
6.

Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.

Gershlick AH, Banning AS, Parker E, Wang D, Budgeon CA, Kelly DJ, Kane PO, Dalby M, Hetherington SL, McCann GP, Greenwood JP, Curzen N.

J Am Coll Cardiol. 2019 Dec 24;74(25):3083-3094. doi: 10.1016/j.jacc.2019.10.033.

PMID:
31856964
7.

Early Oxidative Stress Response in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Transatlantic Study.

Mahmoudi M, Gormaz JG, Erazo M, Howard M, Baeza C, Feelisch M, Curzen N, Olechowski B, Fernandez B, Minnion M, Mikus-Lelinska M, Meiss M, Lau L, Valls N, Gajardo AIJ, Rivotta A, Carrasco R, Cavada G, Vergara MJ, Maluenda G.

Oxid Med Cell Longev. 2019 Nov 13;2019:6217837. doi: 10.1155/2019/6217837. eCollection 2019.

8.

Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.

Rashid M, Curzen N, Kinnaird T, Lawson CA, Myint PK, Kontopantelis E, Mohamed MO, Shoaib A, Gale CP, Timmis A, Mamas MA.

Int J Cardiol. 2020 Feb 15;301:7-13. doi: 10.1016/j.ijcard.2019.11.146. Epub 2019 Nov 28.

PMID:
31810815
9.

Relation of frailty to outcomes in percutaneous coronary intervention.

Kwok CS, Achenbach S, Curzen N, Fischman DL, Savage M, Bagur R, Kontopantelis E, Martin GP, Steg PG, Mamas MA.

Cardiovasc Revasc Med. 2019 Nov 15. pii: S1553-8389(19)30752-3. doi: 10.1016/j.carrev.2019.11.009. [Epub ahead of print]

PMID:
31761641
10.

Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices.

Shoaib A, Kinnaird T, Curzen N, Ludman P, Smith D, Khoo CW, Kontopantelis E, Rashid M, Mohamed M, Nolan J, Zaman A, Mamas MA; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research.

JACC Cardiovasc Interv. 2019 Nov 25;12(22):2286-2295. doi: 10.1016/j.jcin.2019.08.037.

PMID:
31753300
11.

Use of troponins in clinical practice: Evidence against the use of troponins in clinical practice.

Mariathas M, Curzen N.

Heart. 2020 Feb;106(4):251-252. doi: 10.1136/heartjnl-2019-315765. Epub 2019 Oct 31. No abstract available.

PMID:
31672777
12.

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial.

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang CC, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Stoll HP, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Sep 10. pii: EIJ-D-19-00498. doi: 10.4244/EIJ-D-19-00498. [Epub ahead of print]

13.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Jüni P, Head SJ; SYNTAX Extended Survival Investigators.

Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.

PMID:
31488373
14.

Same-Day Discharge After Elective Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society.

Taxiarchi P, Kontopantelis E, Martin GP, Kinnaird T, Curzen N, Banning AP, Ludman P, De Belder M, Rashid M, Sperrin M, Mamas MA.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1479-1494. doi: 10.1016/j.jcin.2019.03.030.

PMID:
31395218
15.

Deoxyribonucleic Acid Repair Activity Is Associated with Healed Coronary Plaque Rupture by Optical Coherence Tomography.

Dan K, Garcia-Garcia HM, Yacob O, Kuku KO, Kolm P, Shah N, Bennett MR, Curzen N, Waksman R, Mahmoudi M.

J Cardiovasc Transl Res. 2019 Dec;12(6):608-610. doi: 10.1007/s12265-019-09904-2. Epub 2019 Jul 31.

PMID:
31367899
16.

Frequency and impact of incidental findings on computed tomography during work-up for transcatheter aortic valve implantation: single centre experience and review of the literature.

Hinton J, Gough S, Ahmed H, Gabara L, Rawlins J, Calver A, Shah BN, Rakhit D, Shambrook J, Harden S, Peebles C, Abbas A, Curzen N.

Br J Radiol. 2019 Oct;92(1102):20190344. doi: 10.1259/bjr.20190344. Epub 2019 Aug 12. Review.

PMID:
31359789
17.

Coronary perforation complicating percutaneous coronary intervention in patients presenting with an acute coronary syndrome: An analysis of 1013 perforation cases from the British Cardiovascular Intervention Society database.

Kinnaird T, Kwok CS, Davies R, Calvert PA, Anderson R, Gallagher S, Sirker A, Ludman P, deBelder M, Stables R, Johnson TW, Kontopantelis E, Curzen N, Mamas M; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Int J Cardiol. 2020 Jan 15;299:37-42. doi: 10.1016/j.ijcard.2019.06.034. Epub 2019 Jun 14.

PMID:
31253528
18.

DNA Damage and Repair in Patients With Coronary Artery Disease: Correlation With Plaque Morphology Using Optical Coherence Tomography (DECODE Study).

Shah N, Meira LB, Elliott RM, Hoole SP, West NE, Brown AJ, Bennett MR, Garcia-Garcia HM, Kuku KO, Dan K, Kolm P, Mariathas M, Curzen N, Mahmoudi M.

Cardiovasc Revasc Med. 2019 Sep;20(9):812-818. doi: 10.1016/j.carrev.2019.04.028. Epub 2019 May 23.

PMID:
31178349
19.

True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study.

Mariathas M, Allan R, Ramamoorthy S, Olechowski B, Hinton J, Azor M, Nicholas Z, Calver A, Corbett S, Mahmoudi M, Rawlins J, Simpson I, Wilkinson J, Kwok CS, Cook P, Mamas MA, Curzen N.

BMJ. 2019 Mar 13;364:l729. doi: 10.1136/bmj.l729.

20.

Fractional flow reserve use during elective coronary angiography among elderly patients in the US.

Kay B, Joseph TA, Lehrich JL, Curzen N, Nallamothu BK.

Int J Cardiol Heart Vasc. 2019 Feb 20;22:160-162. doi: 10.1016/j.ijcha.2019.01.005. eCollection 2019 Mar.

21.

Temporal trends in relative survival following percutaneous coronary intervention.

Hulme WJ, Sperrin M, Martin GP, Curzen N, Ludman P, Kontopantelis E, Mamas MA; British Cardiovascular Intervention Society and the National Institute of Cardiovascular Outcomes Research.

BMJ Open. 2019 Feb 19;9(2):e024627. doi: 10.1136/bmjopen-2018-024627.

22.

Temporal trends and predictors of time to coronary angiography following non-ST-elevation acute coronary syndrome in the USA.

Rashid M, Fischman DL, Martinez SC, Capers Q 4th, Savage M, Zaman A, Curzen N, Ensor J, Potts J, Mohamed MO, Kwok CS, Kinnaird T, Bagur R, Mamas M.

Coron Artery Dis. 2019 May;30(3):159-170. doi: 10.1097/MCA.0000000000000693.

PMID:
30676387
23.

Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Ford TJ, Petrie MC, Macfarlane PW, Tait RC, Welsh P, Sattar N, Weir RA, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.

JAMA. 2019 Jan 1;321(1):56-68. doi: 10.1001/jama.2018.19802.

24.

Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society Database.

Kinnaird T, Anderson R, Gallagher S, Sirker A, Ludman P, de Belder M, Copt S, Oldroyd K, Curzen N, Banning A, Mamas M.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2480-2491. doi: 10.1016/j.jcin.2018.09.035.

25.

Outcomes Following Percutaneous Coronary Intervention in Non-ST-Segment-Elevation Myocardial Infarction Patients With Coronary Artery Bypass Grafts.

Shoaib A, Kinnaird T, Curzen N, Kontopantelis E, Ludman P, de Belder M, Rashid M, Kwok CS, Nolan J, Zaman A, Mamas MA.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006824. doi: 10.1161/CIRCINTERVENTIONS.118.006824.

PMID:
30571201
26.

A randomised controlled trial to compare two coronary pressure wires using simultaneous measurements in human coronary arteries: the COMET trial.

Stables RH, Elguindy M, Kemp I, Nicholas Z, Mars C, Mullen L, Curzen N.

EuroIntervention. 2019 Feb 8;14(15):e1578-e1584. doi: 10.4244/EIJ-D-18-00786.

27.

Comparison of the antiplatelet and antithrombotic effects of bivalirudin versus unfractionated heparin: A platelet substudy of the HEAT PPCI trial.

Khanna V, Shahzad A, Thayalasamy K, Kemp I, Mars C, Cooper R, Roome C, Wilson K, Harris S, Stables R, Curzen N.

Thromb Res. 2018 Dec;172:36-43. doi: 10.1016/j.thromres.2018.09.062. Epub 2018 Sep 28.

PMID:
30359789
28.

Changes in Periprocedural Bleeding Complications Following Percutaneous Coronary Intervention in The United Kingdom Between 2006 and 2013 (from the British Cardiovascular Interventional Society).

Olier I, Carr M, Curzen N, Ludman P, Baumbach A, Kinnaird T, de Belder MA, Hildick-Smith D, Sirker A, Kwok CS, Rashid M, Nolan J, Kontopantelis E, Mamas MA.

Am J Cardiol. 2018 Sep 15;122(6):952-960. doi: 10.1016/j.amjcard.2018.06.016. Epub 2018 Jul 8.

PMID:
30131105
29.

Temporal Changes in Co-Morbidity Burden in Patients Having Percutaneous Coronary Intervention and Impact on Prognosis.

Potts J, Kwok CS, Ensor J, Rashid M, Kadam U, Kinnaird T, Curzen N, Pancholy SB, Van der Windt D, Riley RD, Bagur R, Mamas MA.

Am J Cardiol. 2018 Sep 1;122(5):712-722. doi: 10.1016/j.amjcard.2018.05.003. Epub 2018 Jun 19.

PMID:
30072123
30.

Effect of Comorbidity On Unplanned Readmissions After Percutaneous Coronary Intervention (From The Nationwide Readmission Database).

Kwok CS, Martinez SC, Pancholy S, Ahmed W, Al-Shaibi K, Potts J, Mohamed M, Kontopantelis E, Curzen N, Mamas MA.

Sci Rep. 2018 Jul 24;8(1):11156. doi: 10.1038/s41598-018-29303-y.

31.

Troponin assays: developing indications.

Mariathas M, Curzen N.

Lancet. 2018 Jun 16;391(10138):2398-2399. doi: 10.1016/S0140-6736(17)32342-5. No abstract available.

PMID:
29916372
32.

Temporal Trends in Identification, Management, and Clinical Outcomes After Out-of-Hospital Cardiac Arrest: Insights From the Myocardial Ischaemia National Audit Project Database.

Patterson T, Perkins GD, Hassan Y, Moschonas K, Gray H, Curzen N, de Belder M, Nolan JP, Ludman P, Redwood SR.

Circ Cardiovasc Interv. 2018 Jun;11(6):e005346. doi: 10.1161/CIRCINTERVENTIONS.117.005346.

PMID:
29871939
33.

Health Economic Analysis of Access Site Practice in England During Changes in Practice: Insights From the British Cardiovascular Interventional Society.

Mamas MA, Tosh J, Hulme W, Hoskins N, Bungey G, Ludman P, de Belder M, Kwok CS, Verin N, Kinnaird T, Bennett E, Curzen N, Nolan J, Kontopantelis E.

Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004482. doi: 10.1161/CIRCOUTCOMES.117.004482.

PMID:
29743163
34.

The role of mineralocorticoid receptor antagonists in patients with acute myocardial infarction: Is the evidence reflective of modern clinical practice?

Hinton J, Mahmoudi M, Myat A, Curzen N.

Cardiovasc Revasc Med. 2018 Jun;19(4):452-456. doi: 10.1016/j.carrev.2018.04.012. Epub 2018 Apr 17. Review. No abstract available.

PMID:
29730238
35.

Detection of individual responses to clopidogrel: Validation of a novel, rapid analysis using thrombelastography 6s.

Olechowski B, Dalton RT, Khanna V, Ashby A, Vavyla M, Mariathas M, Harris S, Nicholas Z, Mahmoudi M, Curzen N.

Cardiovasc Ther. 2018 Aug;36(4):e12433. doi: 10.1111/1755-5922.12433. Epub 2018 May 25.

PMID:
29682911
36.

Hobson's Choice: Platelet Inhibition and Thrombocytopenia.

Mamas MA, Curzen N.

Circ Cardiovasc Interv. 2018 Apr;11(4):e006577. doi: 10.1161/CIRCINTERVENTIONS.118.006577. No abstract available.

PMID:
29632239
37.

Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.

Kwok CS, Rao SV, Potts JE, Kontopantelis E, Rashid M, Kinnaird T, Curzen N, Nolan J, Bagur R, Mamas MA.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.

38.

Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.

Hulme W, Sperrin M, Curzen N, Kinnaird T, De Belder MA, Ludman P, Kwok CS, Gale CP, Cockburn J, Kontopantelis E, Mamas MA; British Cardiovascular Intervention Society and the National Institute of Cardiovascular Outcomes Research.

Eur Heart J. 2018 May 7;39(18):1623-1634. doi: 10.1093/eurheartj/ehy125.

PMID:
29579219
39.

Physiology-Guided Management of Serial Coronary Artery Disease: A Review.

Modi BN, De Silva K, Rajani R, Curzen N, Perera D.

JAMA Cardiol. 2018 May 1;3(5):432-438. doi: 10.1001/jamacardio.2018.0236. Review.

PMID:
29562079
40.

MicroRNA 8059 as a marker for the presence and extent of coronary artery calcification.

Howlett P, Cleal JK, Wu H, Shah N, Horton A, Curzen N, Mahmoudi M.

Open Heart. 2018 Jan 31;5(1):e000678. doi: 10.1136/openhrt-2017-000678. eCollection 2018.

42.

Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.

Olier I, Sirker A, Hildick-Smith DJR, Kinnaird T, Ludman P, de Belder MA, Baumbach A, Byrne J, Rashid M, Curzen N, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Heart. 2018 Oct;104(20):1683-1690. doi: 10.1136/heartjnl-2017-312366. Epub 2018 Feb 2.

PMID:
29437885
43.

High sensitivity troponin in the management of tachyarrhythmias.

Mariathas M, Gemmell C, Olechowski B, Nicholas Z, Mahmoudi M, Curzen N.

Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):487-492. doi: 10.1016/j.carrev.2017.11.011. Epub 2017 Nov 28.

PMID:
29352700
44.

Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.

Shahzad A, Khanna V, Kemp I, Shaw M, Mars C, Cooper R, Wilson K, Curzen N, Stables RH.

EuroIntervention. 2018 Mar 20;13(16):1931-1938. doi: 10.4244/EIJ-D-17-00408.

45.

Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.

Godschalk TC, Byrne RA, Adriaenssens T, Malik N, Feldman LJ, Guagliumi G, Alfonso F, Neumann FJ, Trenk D, Joner M, Schulz C, Steg PG, Goodall AH, Wojdyla R, Dudek D, Wykrzykowska JJ, Hlinomaz O, Zaman AG, Curzen N, Dens J, Sinnaeve P, Desmet W, Gershlick AH, Kastrati A, Massberg S, Ten Berg JM; PRESTIGE Investigators.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2548-2556. doi: 10.1016/j.jcin.2017.09.019.

46.

High sensitivity troponins in contemporary cardiology practice: are we turning a corner?

Mariathas M, Olechowski B, Mahmoudi M, Curzen N.

Expert Rev Cardiovasc Ther. 2018 Jan;16(1):49-57. doi: 10.1080/14779072.2018.1419063. Epub 2017 Dec 28. Review.

PMID:
29260921
47.

Changes in platelet function with inflammation in patients undergoing vascular surgery.

Olechowski B, Khanna V, Mariathas M, Ashby A, Dalton RT, Nordon I, Englyst N, Harris S, Nicholas Z, Thayalasamy K, Mahmoudi M, Curzen N.

Platelets. 2019;30(2):190-198. doi: 10.1080/09537104.2017.1392498. Epub 2017 Dec 11.

PMID:
29227173
48.

Transcatheter aortic valve implantation: where are we now?

Mariathas M, Rawlins J, Curzen N.

Future Cardiol. 2017 Nov;13(6):551-566. doi: 10.2217/fca-2017-0056. Epub 2017 Oct 24. Review.

PMID:
29064293
49.

Response by Piroth et al to Letter Regarding Article, "Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation".

Piroth Z, Toth GG, Tonino PAL, Barbato E, Aghlmandi S, Curzen N, Rioufol G, Pijls NHJ, Fearon WF, Jüni P, De Bruyne B.

Circ Cardiovasc Interv. 2017 Oct;10(10). pii: e005973. doi: 10.1161/CIRCINTERVENTIONS.117.005973. No abstract available.

PMID:
29038228
50.

Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation.

Piroth Z, Toth GG, Tonino PAL, Barbato E, Aghlmandi S, Curzen N, Rioufol G, Pijls NHJ, Fearon WF, Jüni P, De Bruyne B.

Circ Cardiovasc Interv. 2017 Aug;10(8). pii: e005233. doi: 10.1161/CIRCINTERVENTIONS.116.005233.

Supplemental Content

Loading ...
Support Center